2,17 $
0,00 % vorgestern
Nasdaq, 3. Oktober, 22:12 Uhr
ISIN
KYG8884K1022
Symbol
TIRX
Berichte

Tian Ruixiang Holdings Ltd - Ordinary Shares - Class A Aktie News

Neutral
GlobeNewsWire
etwa ein Monat alt
BEIJING, Sept. 02, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd.
Neutral
GlobeNewsWire
etwa 2 Monate alt
Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on Tian Ruixiang Holdings Limited (NASDAQ: TIRX) titled, “From Traditional Insurance Broker to Tech- Based Health Insurance Innovator”. The report can be accessed here. Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on Tian Ruixiang Holdings Limited ...
Neutral
GlobeNewsWire
3 Monate alt
BEIJING, June 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) (the “Company” or “TRX”), a China-based insurance broker, today announced it has completed the acquisition of 100% of issued and outstanding shares of Ucare Inc. (“Ucare”), the sole operator of China's only cloud-based AI-driven hospital and health insurance risk management platform. The all-stock transaction, ...
Neutral
GlobeNewsWire
4 Monate alt
BEIJING, May 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) (the "Company" or “TRX”), a China-based insurance broker, today announced plans to acquire 100% of issued and outstanding shares of Ucare Inc. (“Ucare”), the sole operator of China's only cloud-based AI-driven hospital and health insurance risk management platform, in an all-share deal valued at US$150 million. ...

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen